These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37667483)

  • 41. Impact Of The COVID-19 Pandemic on Hospital Admissions and In-Hospital Lethality From Cardiovascular Diseases in Brazil: An Ecological and Time Series Study.
    Santos LG; da Silva RV; Leal TC; Xavier JE; Figueiredo EVMS; de Paiva JPS; da Silva LF; Rocha CAO; Nunes BEBR; Santana GBA; Fernandes TRMO; Costa FA; Bezerra-Santos M; Feliciano do Carmo R; Armstrong ADC; de Souza CDF
    Curr Probl Cardiol; 2023 Aug; 48(8):101216. PubMed ID: 35460687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Impact of the Coronavirus Disease 2019 Pandemic on Neurosurgical Practice and Feasibility of Safe Resumption of Elective Procedures During this Era in a Large Referral Center in Tehran, Iran: An Unmatched Case-Control Study.
    Tavanaei R; Ahmadi P; Yazdani KO; Zali A; Oraee-Yazdani S
    World Neurosurg; 2021 Oct; 154():e370-e381. PubMed ID: 34284156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. One train may hide another: Acute cardiovascular diseases could be neglected because of the COVID-19 pandemic.
    Huet F; Prieur C; Schurtz G; Gerbaud E; Manzo-Silberman S; Vanzetto G; Elbaz M; Tea V; Mercier G; Lattuca B; Duflos C; Roubille F
    Arch Cardiovasc Dis; 2020 May; 113(5):303-307. PubMed ID: 32362433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In-hospital care in acute heart failure during the COVID-19 pandemic: insights from the German-wide Helios hospital network.
    König S; Hohenstein S; Meier-Hellmann A; Kuhlen R; Hindricks G; Bollmann A;
    Eur J Heart Fail; 2020 Dec; 22(12):2190-2201. PubMed ID: 33135851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of Cardiovascular Disease on the Death Certificate Diagnosis of Heart Failure, Ischemic Heart Disease, and Cerebrovascular Disease　- The Japan Public Health Center-Based Prospective Study.
    Saito I; Yamagishi K; Kokubo Y; Yatsuya H; Iso H; Sawada N; Inoue M; Tsugane S
    Circ J; 2023 Aug; 87(9):1196-1202. PubMed ID: 36948630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insights into heart failure hospitalizations, management, and services during and beyond COVID-19.
    Charman SJ; Velicki L; Okwose NC; Harwood A; McGregor G; Ristic A; Banerjee P; Seferovic PM; MacGowan GA; Jakovljevic DG
    ESC Heart Fail; 2021 Feb; 8(1):175-182. PubMed ID: 33232587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sudden cardiovascular death rate and ischaemic heart disease death rate changes during the 5-year period of 2003-2008.
    Piotrowski W; Polakowska M; Koziarek J; Broda G
    Kardiol Pol; 2012; 70(12):1225-34. PubMed ID: 23264239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of the COVID-19 pandemic on cardiovascular heart disease medication use: time-series analysis of England's prescription data during the COVID-19 pandemic (January 2019 to October 2020).
    Barrett R; Hodgkinson J
    Ther Adv Cardiovasc Dis; 2022; 16():17539447221137170. PubMed ID: 36420815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of COVID-19 pandemic on patients with cardio/cerebrovascular disease who visit the emergency department.
    Park B; Bae W; Kim HJ; Lim JY; Oh SH; Youn CS; Kim HJ; Park KN; Song H
    Am J Emerg Med; 2022 Aug; 58():100-105. PubMed ID: 35660366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current trends in admissions and outcomes of cardiac diseases in Ghana.
    Appiah LT; Sarfo FS; Agyemang C; Tweneboah HO; Appiah NABA; Bedu-Addo G; Opare-Sem O
    Clin Cardiol; 2017 Oct; 40(10):783-788. PubMed ID: 28692760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of exposure to long working hours on ischaemic heart disease: A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.
    Li J; Pega F; Ujita Y; Brisson C; Clays E; Descatha A; Ferrario MM; Godderis L; Iavicoli S; Landsbergis PA; Metzendorf MI; Morgan RL; Pachito DV; Pikhart H; Richter B; Roncaioli M; Rugulies R; Schnall PL; Sembajwe G; Trudel X; Tsutsumi A; Woodruff TJ; Siegrist J
    Environ Int; 2020 Sep; 142():105739. PubMed ID: 32505014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. "Decline and uneven recovery from 7 common long-term conditions managed in the Catalan primary care after two pandemic years: an observational retrospective population-based study using primary care electronic health records".
    Mora N; Fina F; Méndez-Boo L; Cantenys R; Benítez M; Moreno N; Balló E; Hermosilla E; Fàbregas M; Guiriguet C; Cos X; Rodoreda S; Mas A; Lejardi Y; Coma E; Medina M
    BMC Prim Care; 2023 Jan; 24(1):9. PubMed ID: 36641483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The evolution of mortality from ischemic heart disease and cerebrovascular diseases in Portugal in the decade of the 80s].
    de Sá P; Dias JA; Miguel JM
    Acta Med Port; 1994 Feb; 7(2):71-81. PubMed ID: 8178695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
    Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regional variations in cardiovascular mortality in Canada.
    Filate WA; Johansen HL; Kennedy CC; Tu JV
    Can J Cardiol; 2003 Oct; 19(11):1241-8. PubMed ID: 14571309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploration of Cardiology Patient Hospital Presentations, Health Care Utilisation and Cardiovascular Risk Factors During the COVID-19 Pandemic.
    Cho K; Femia G; Lee R; Nageswararajah D; Doulatram H; Kadappu K; Juergens C
    Heart Lung Circ; 2023 Mar; 32(3):348-352. PubMed ID: 36604223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular Disease Prevention and Implications of Coronavirus Disease 2019: An Evolving Case Study in the Crescent City.
    Razavi AC; Kelly TN; He J; Fernandez C; Whelton PK; Krousel-Wood M; Bazzano LA
    J Am Heart Assoc; 2020 Jul; 9(13):e016997. PubMed ID: 32418463
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact in total ischemic time and ST-segment elevation myocardial infarction admissions during COVID-19.
    Bruoha S; Yosefy C; Gallego-Colon E; Rieck J; Orlov Y; Osherov A; Jihad AH; Sherer Y; Viki N; Jafari J
    Am J Emerg Med; 2021 Jul; 45():7-10. PubMed ID: 33640628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trends in 30-day readmissions following hospitalisation for heart failure by sex, socioeconomic status and ethnicity.
    Lawson C; Crothers H; Remsing S; Squire I; Zaccardi F; Davies M; Bernhardt L; Reeves K; Lilford R; Khunti K
    EClinicalMedicine; 2021 Aug; 38():101008. PubMed ID: 34308315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.